(Q33602888)

28 July 2017

1 reference

title

Mineralocorticoid hypertension (English)

1 reference

28 July 2017

1 reference

P M Stewart

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

353

1 reference

28 July 2017

issue

9161

1 reference

28 July 2017

page(s)

1341-1347

1 reference

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Hemodynamic Characteristics of Primary Aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Colocalization of 11 beta-hydroxysteroid dehydrogenase and mineralocorticoid receptors in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Carbenoxolone damages endothelium and enhances vasoconstrictor action in aortic rings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

High incidence of primary aldosteronism in 199 patients referred with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Primary aldosteronism: hypertension with a genetic basis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

The diagnosis of primary aldosteronism and separation of two major subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

The myth of idiopathic hyperaldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Use of computed tomography in diagnosing the cause of primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Scintigraphic localization of adrenal lesions in primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Reassessment of the predictive value of the postural stimulation test in primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Primary aldosteronism: adrenal venous sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

The Effect of Triamterene and Sodium Intake on Renin, Aldosterone, and Erythrocyte Sodium Transport in Liddle’s Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Brief report: Liddle's syndrome revisited--a disorder of sodium reabsorption in the distal tubule

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

A Syndrome of Apparent Mineralocorticoid Excess Associated with Defects in the Peripheral Metabolism of Cortisol*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

The Syndrome of Apparent Mineralocorticoid Excess: Its Association with 1 lβ –Dehydrogenase and 5β –Reductase Deficiency and Some Consequences for Corticosteroid Metabolism*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Apparent mineralocorticoid excess in a Brazilian kindred

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Apparent mineralocorticoid excess: genotype is correlated with biochemical phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Licorice-induced hypermineralocorticoidism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Impact of dietary Na+ on glycyrrhetinic acid-like factors (kidney 11beta-(HSD2)-GALFs) in human essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Genetic association of 11 beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Hormones and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

The changing clinical spectrum of primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Adrenalectomy in primary aldosteronism: a long-term follow-up study in 52 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Primary aldosteronism (Conn's syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Plasma aldosterone response to ACTH in subtypes of primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Laparoscopic trans-peritoneal adrenalectomy: a preliminary report of 14 adrenalectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Liddle's disease: abnormal regulation of amiloride-sensitive Na+ channels by beta-subunit mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

New findings in apparent mineralocorticoid excess

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

11 beta-Hydroxysteroid dehydrogenase: implications for clinical medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906102-9

7 January 2021

10.1016/S0140-6736(98)06102-9

Identifiers

DOI

1 reference

28 July 2017

1 reference